Answers are grounded in this paper and cite their sources.
T he fi rst laboratory-confi rmed case of corona- virus disease in South Africa was reported on March 5, 2020, and the country has since experienced 2 waves of COVID-19, the fi rst peaking in July 2020 and the second in January 2021 (1).Across Africa, the second wave was more severe than the fi rst (2), and specifi cally in South Africa, higher weekly incidence, hospitalizations, and deaths were reported for the second wave, compared with the fi rst (3-5).The second wave in South Africa was coupled with the emergence of a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.351,also known as 501Y.V2 or Beta (6).South Africa reported >1.6 million laboratoryconfi rmed cases by mid-May 2021 (3), but many cases go undiagnosed because of mild or absent symptoms or the lack of (or reluctance to access) care or testing.Data on the proportion of persons with serologic evidence of prior SARS-CoV-2 infection are critical to assess infection rates, calculate infection-hospitalization ratios (IHRs) and infection-fatality ratios (IFRs), compare infection prevalence between waves of infection and to guide public health responses (7).SARS-CoV-2 seroprevalence is higher in close contacts of case-patients and at-risk healthcare workers and lower in persons <20 years of age or >65 years SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa,
No takes yet. Share an insight, caveat, or question.
Kleynhans et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: